| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |